These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36902587)

  • 41. Preliminary characterizations of a serum biomarker for sarcoidosis by comparative proteomic approach with tandem-mass spectrometry in ethnic Han Chinese patients.
    Zhang Y; Chen X; Hu Y; Du S; Shen L; He Y; Zhang Y; Zhang X; Li H; Yung RC
    Respir Res; 2013 Feb; 14(1):18. PubMed ID: 23399022
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of novel biomarkers for adult-onset-immunodeficiency (AOID) syndrome using serum proteomics.
    Wongtrakul J; Thongtan T; Roytrakul S; Praparattanapan J; Wipasa J; Kumrapich B; Supparatpinyo K
    Asian Pac J Trop Med; 2017 May; 10(5):466-472. PubMed ID: 28647184
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differences in expression of serum protein in patients with psoriasis vulgaris and blood heat syndrome and healthy volunteers.
    Hao PS; Yang C; Yan XP; Li TH; Zhang J; Yu QY; Zhang X; Zhang YH
    Cell Mol Biol (Noisy-le-grand); 2017 Aug; 63(8):38-41. PubMed ID: 28886312
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of psoriasis vulgaris biomarkers in human plasma by non-targeted metabolomics based on UPLC-Q-TOF/MS.
    Li SS; Liu Y; Li H; Wang LP; Xue LF; Yin GS; Wu XS
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3940-3950. PubMed ID: 31115022
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 2-DE and LC-MS/MS for a comparative proteomic analysis of BALf from subjects with different subsets of inflammatory myopathies.
    Passadore I; Iadarola P; Di Poto C; Giuliano S; Montecucco C; Cavagna L; Bonino C; Meloni F; Fietta AM; Lisa A; Salvini R; Bardoni AM
    J Proteome Res; 2009 May; 8(5):2331-40. PubMed ID: 19301896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Prognostic significance of plasma gelsolin in severe burn patients with sepsis].
    Huang L; Yao Y; Dong N; He L; Zhang Q; Yu Y; Sheng Z
    Zhonghua Shao Shang Za Zhi; 2016 Feb; 32(2):77-81. PubMed ID: 26902273
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proteomic biomarkers for psoriasis and psoriasis arthritis.
    Reindl J; Pesek J; Krüger T; Wendler S; Nemitz S; Muckova P; Büchler R; Opitz S; Krieg N; Norgauer J; Rhode H
    J Proteomics; 2016 May; 140():55-61. PubMed ID: 27063990
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunoproteomic analysis of potential serum biomarker candidates in human glaucoma.
    Tezel G; Thornton IL; Tong MG; Luo C; Yang X; Cai J; Powell DW; Soltau JB; Liebmann JM; Ritch R
    Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8222-31. PubMed ID: 23150628
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Investigating the Correlation between Growth Differentiation Factor 15 Serum Level and Its Gene Expression with Psoriasis and Its Severity.
    Akbari H; Talaee R; Zaker SF; Nikoueinejad H
    Iran J Allergy Asthma Immunol; 2021 Sep; 20(5):593-599. PubMed ID: 34664818
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Significant reduction of plasma gelsolin levels in patients with intracerebral hemorrhage.
    Zhao DQ; Wang K; Zhang HD; Li YJ
    Clin Chim Acta; 2013 Jan; 415():202-6. PubMed ID: 23142649
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantitative proteomic analysis of the cerebrospinal fluid of patients with multiple sclerosis.
    Liu S; Bai S; Qin Z; Yang Y; Cui Y; Qin Y
    J Cell Mol Med; 2009 Aug; 13(8A):1586-603. PubMed ID: 19602050
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proteomic Analysis of Serum Amyloid A as a Potential Marker in Intestinal Behçet's Disease.
    Lee HJ; Kim JH; Kim SW; Joo HA; Lee HW; Kim YS; Park SJ; Hong SP; Kim TI; Kim WH; Kim YH; Cheon JH
    Dig Dis Sci; 2017 Aug; 62(8):1953-1962. PubMed ID: 28523576
    [TBL] [Abstract][Full Text] [Related]  

  • 53. iTRAQ-Based Proteomic Analysis Reveals Potential Serum Biomarkers for Pediatric Non-Hodgkin's Lymphoma.
    Yu R; Cheng L; Yang S; Liu Y; Zhu Z
    Front Oncol; 2022; 12():848286. PubMed ID: 35371990
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum vascular endothelial growth factor, transforming growth factor β1, and nitric oxide levels in patients with psoriasis vulgaris: their correlation to disease severity.
    Meki AR; Al-Shobaili H
    J Clin Lab Anal; 2014 Nov; 28(6):496-501. PubMed ID: 24659464
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proteomic profiling for the identification of serum diagnostic biomarkers for abdominal and thoracic aortic aneurysms.
    Satoh K; Maniwa T; Oda T; Matsumoto K
    Proteome Sci; 2013 Jun; 11(1):27. PubMed ID: 23802875
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeting TNFα in severe psoriasis-mass spectrometry reveals a time-dependent specific inhibition of Factor H in responding patients.
    Morlière P; Antunes JF; Nourry V; Amado FM; Domingues PM; Guerreiro AC; Ferreira JA; Maia-Silva JN; Mazière JC; Santus RC; Filipe PL
    Am J Transl Res; 2018; 10(12):4338-4349. PubMed ID: 30662676
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum Concentrations of Interferon Gamma (IFN-γ) in Patients with Psoriasis: Correlation with Clinical Type and Severity of the Disease.
    Kurtovic NO; Halilovic EK
    Med Arch; 2018 Dec; 72(6):410-413. PubMed ID: 30814771
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biomarkers of HIV-1 associated dementia: proteomic investigation of sera.
    Wiederin J; Rozek W; Duan F; Ciborowski P
    Proteome Sci; 2009 Mar; 7():8. PubMed ID: 19292902
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of secretory gelsolin as a plasma biomarker associated with distant organ metastasis of colorectal cancer.
    Tsai MH; Wu CC; Peng PH; Liang Y; Hsiao YC; Chien KY; Chen JT; Lin SJ; Tang RP; Hsieh LL; Yu JS
    J Mol Med (Berl); 2012 Feb; 90(2):187-200. PubMed ID: 21997591
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative mass spectrometric and immunoassay-based proteome analysis in serum of Duchenne muscular dystrophy patients.
    Oonk S; Spitali P; Hiller M; Switzar L; Dalebout H; Calissano M; Lochmüller H; Aartsma-Rus A; 't Hoen PA; van der Burgt YE
    Proteomics Clin Appl; 2016 Mar; 10(3):290-9. PubMed ID: 26680509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.